-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Underweight on HCA Healthcare, Lowers Price Target to $380

Benzinga·07/27/2026 16:30:49
Listen to the news
Morgan Stanley analyst Craig Hettenbach maintains HCA Healthcare (NYSE:HCA) with a Underweight and lowers the price target from $425 to $380.